Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers studied Paliperidone ER to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedA Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
This study ended early.
Multiple locations, including Santa RosaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyA Phase 1, Open-label, Single-sequence Pharmacokinetic Trial to Assess the Effect of a Single Oral Dose of SEP-380135 on the Potential for Cytochrome P4502D6 Mediated Drug-drug Interactions in Healthy Adults
This study has finished and is no longer accepting participants.
In Overland ParkA Randomized, Open-label, Single Dose, Crossover Trial to Assess the Effects of Food on the Pharmacokinetics of 10 mg Emestedastat Tablet in Healthy Adult Participants
This study has finished and is no longer accepting participants.
In Australia
A Tripartite Biopsychosocial Intervention Program Enhances Mental Health and Quality of Life in Elderly Patients With Depression Secondary to Geriatric Diseases
This study has finished and is no longer accepting participants.
In WenzhouA Twelve Week, Multicenter, Open Label Extension Study in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Two-Arm, Open-Label, Multi-Location, Single Center Study of the Craving Profile of the Nicotine Replacement Therapy Chrono Quit Smoking Solution (CQSS2; 21 mg) versus NiQuitin (registered trademark) Patch (21 mg) for Smoking Cessation in Treatment Seeking Subjects
This study has finished and is no longer accepting participants.
In AustraliaA United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Read the official source — NCT00208156Researchers studied Mifepristone to find out how it affected psychotic symptoms in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including San DiegoA United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
Read the official source — NCT00130676Researchers compared Mifepristone and placebo, tracking side effects to assess safety in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Pico RiveraA United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
Read the official source — NCT00128479Researchers compared mifepristone, mifepristone 600 mg, mifepristone 1200 mg and placebo, tracking side effects to assess safety in people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
A Usability Assessment of Intramuscular, Atomized Intranasal, and Nasal Spray Administration of Naloxone by Untrained Community Members
This study has finished and is no longer accepting participants.
In SyracuseWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.